Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 301 AL 315

Cerebral amyloid angiopathy-related microhemorrhages in Alzheimer's disease: a review of investigative animal models

Chen H, Zhang JH.

Acta Neurochir Suppl. 2011;111:15-7. doi: 10.1007/978-3-7091-0693-8_3.

Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?

Marchetti C, Marie H.

Rev Neurosci. 2011;22(4):373-402. doi: 10.1515/RNS.2011.035. Epub 2011 Jul 6.

Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration

Pac-Soo C, Lloyd DG, Vizcaychipi MP, Ma D.

J Alzheimers Dis. 2011;27(1):1-10. doi: 10.3233/JAD-2011-110524.

Alzheimer's disease: cholesterol a menace?

Mathew A, Yoshida Y, Maekawa T, Kumar DS.

Brain Res Bull. 2011 Aug 10;86(1-2):1-12. doi: 10.1016/j.brainresbull.2011.06.006. Epub 2011 Jul 1.

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

Wallace TL, Porter RH.

Biochem Pharmacol. 2011 Oct 15;82(8):891-903. doi: 10.1016/j.bcp.2011.06.034. Epub 2011 Jul 2.

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats

Tramontina AC, Wartchow KM, Rodrigues L, Biasibetti R, Quincozes-Santos A, Bobermin L, Tramontina F, Gonçalves CA.

J Neural Transm (Vienna). 2011 Nov;118(11):1641-9. doi: 10.1007/s00702-011-0680-z. Epub 2011 Jul 10.

Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential

Hanke ML, Kielian T.

Clin Sci (Lond). 2011 Nov;121(9):367-87. doi: 10.1042/CS20110164.

Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility

Kopits IM, Chen C, Roberts JS, Uhlmann W, Green RC.

Genet Test Mol Biomarkers. 2011 Dec;15(12):871-5. doi: 10.1089/gtmb.2011.0028. Epub 2011 Jul 12.

Rivastigmine associated hyponatremia in an older patient with Alzheimer's disease

Naharci IM, Bozoglu E, Karadurmus N, Karaman M, Kurt O, Doruk H.

J Am Geriatr Soc. 2011 Jul;59(7):1351-2. doi: 10.1111/j.1532-5415.2011.03468.x.

Roles of p75NTR in the pathogenesis of Alzheimer's disease: a novel therapeutic target

Zeng F, Lu JJ, Zhou XF, Wang YJ.

Biochem Pharmacol. 2011 Nov 15;82(10):1500-9. doi: 10.1016/j.bcp.2011.06.040. Epub 2011 Jul 5.

Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

Parri HR, Hernandez CM, Dineley KT.

Biochem Pharmacol. 2011 Oct 15;82(8):931-42. doi: 10.1016/j.bcp.2011.06.039. Epub 2011 Jul 7.

AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America

Westman E, Simmons A, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Weiner MW, Lovestone S, Spenger C, Wahlund LO; AddNeuroMed consortium; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Oct 1;58(3):818-28. doi: 10.1016/j.neuroimage.2011.06.065. Epub 2011 Jul 1.

Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease

Menuet C, Borghgraef P, Matarazzo V, Gielis L, Lajard AM, Voituron N, Gestreau C, Dutschmann M, Van Leuven F, Hilaire G.

Respir Physiol Neurobiol. 2011 Sep 15;178(2):290-303. doi: 10.1016/j.resp.2011.06.030. Epub 2011 Jul 6.

A novel operant testing regimen for multi-construct cognitive characterization of a murine model of Alzheimer's amyloid-related behavioral impairment

Blackshear AL, Xu W, Anderson M, Xu F, Previti ML, Van Nostrand WE, Robinson JK.

Neurobiol Learn Mem. 2011 Oct;96(3):443-51. doi: 10.1016/j.nlm.2011.06.017. Epub 2011 Jul 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias